Medical Devices Startups
6,551 companies tagged Medical Devices, with their investors and founders.
Slipstream Solutions develops medical technology to address fluid stasis and support recovery and rehabilitation for caregivers, trainers, and patients, with a focus on underserved populations.
0 investors
Sommetrics develops a non-invasive medical device using proprietary vacuum technology applied to the neck to reduce airway narrowing associated with obstructive sleep apnea and chronic snoring. The company targets patients seeking alternatives to existing sleep apnea treatments.
0 investors
Sonablate Corp. develops HIFU (high-intensity focused ultrasound) technology for focal therapy, initially applied to treating prostate disease as an alternative to conventional treatments. Its systems are used by physicians, with plans to address a broader range of medical conditions.
0 investors
Sonex Health develops ultrasound-guided medical devices for orthopedic conditions, including UltraGuideCTR, a device that enables carpal tunnel release to be performed in a clinic setting. The company targets physicians and healthcare providers seeking minimally invasive treatments with faster patient recovery.
0 investors
Sonivate Medical develops ultrasound-based medical devices, drawing on expertise in cardiac ultrasound and medical device engineering. The company is based in Portland, Oregon.
0 investors
SonoCinΓ© develops an automated whole-breast ultrasound (AWBUS) system used alongside mammography to detect invasive breast cancer, particularly in women with dense breast tissue. The technology is used by radiology practices to find cancers not visible on mammograms.
0 investors
A neuroscience company developing medical solutions based on brain imaging and neurological research for clinical and research applications.
0 investors
South Broward Endoscopy is an outpatient endoscopy center providing gastroenterological procedures in a non-hospital setting. The facility serves patients seeking digestive health services in a personalized, cost-effective environment.
0 investors
Spinnaker Biosciences develops porous silicon, porous silicon oxide, and silicon/polymer composite materials engineered as controlled-release drug delivery vehicles. Its biocompatible, biodegradable particles provide protected storage and sustained release of therapeutic payloads, with surface chemistry that supports targeting agents such as peptides and antibodies.
0 investors
Spiral Therapeutics is a clinical-stage pharmaceutical company developing therapies for balance disorders and hearing loss using its Minimally Invasive Cochlear System (MICS) drug delivery platform. Its lead program, SPT-2101, is a sustained-release dexamethasone formulation for treating Ménière's disease.
0 investors
SS Innovations International develops surgical robotic systems, including the SSi Mantra platform, for use in robotic surgery such as cardiothoracic procedures. The medical technology company focuses on making robotic surgery more affordable and accessible to underserved populations.
0 investors
St Teresa Medical develops nanotechnology-based hemostatic and wound-healing solutions for surgical applications, derived from battlefield trauma treatment technology. The company targets the hemostatic and therapeutic markets with fibers designed to control bleeding and support wound healing during surgery.
0 investors
StairAssist Walker (SAW) makes a mobility device engineered for use on stairs, intended for rehab patients who otherwise improvise to get up and down stairs at home. Invented by a Doctor of Physical Therapy and clinically evaluated with rehab hospitals, it holds three USPTO utility patents.
0 investors
Starton Therapeutics is a clinical-stage biotechnology company that reformulates FDA-approved drugs using proprietary controlled delivery systems to improve their pharmacokinetic profiles. It develops subcutaneous, oral, and transdermal delivery methods aimed at achieving better outcomes in existing or new indications.
0 investors
Stem Cell Reserve (SCR) operates a hybrid private and public umbilical cord blood and cord tissue biobank, using proprietary methods to store cord products and manufacture cord-derived stem cell and biomatrix products for regenerative medicine. The company serves expectant parents (private banking) and donors (public banking), initially focusing on the Houston Metropolitan Area with plans to expand across major U.S. cities.
0 investors
Stemina Biomarker Discovery develops in vitro assays using human stem cell-derived cells to predict drug toxicity and support drug discovery and development. The company serves pharmaceutical and biotech firms seeking developmental and cardiac safety screening.
0 investors
Strategic Radiology is a coalition of independently owned radiology practices that collaborate to improve operational efficiency and quality in diagnostic imaging services. The network is 100% physician-owned and works to sustain private practice radiology in response to consolidation pressures.
0 investors
StrΕma Medical Corporation is a clinical-stage medical device company that has developed a patented laser system to permanently change eye color from brown, hazel, or black to lighter natural shades by removing surface iris pigment in an in-office procedure. The system is intended to be leased to refractive ophthalmologists worldwide.
0 investors
Sulfagenix develops SG1002, an oral hydrogen sulfide prodrug designed to treat oxidative stress-related diseases including cardiovascular disorders, cancer, and other chronic conditions. The company targets patients with conditions ranging from heart failure to cancer, diabetes, and neurodegeneration.
0 investors
SummaCor develops medical device technologies, including the LCAPP, for cardiac care led by a team of cardiologists and engineers. The company focuses on heart-related medical technology with clinical and advisory input from cardiology and heart failure specialists.
0 investors
Surface Ophthalmics is a biopharmaceutical company developing topical eyedrop treatments for dry eye syndrome and post-surgical ocular conditions. The company has evaluated multiple formulations through Phase II clinical trials and is pursuing three proprietary candidates for commercialization.
0 investors
The Surgery Center of Fairbanks is an outpatient surgical facility offering procedures such as robotic-assisted joint replacements using Mako technology. It serves patients in Interior Alaska and provides online pre-registration for surgery day.
0 investors
Surgical Suites of Coastal Virginia is a surgical care provider offering specialized services in ENT, orthopedic, and urology for patients in coastal Virginia.
0 investors
SymbioCellTech develops a cell therapy called "Neo-Islets" intended to treat Type 1 Diabetes without daily insulin injections or immunosuppressive anti-rejection drugs. The company targets the estimated 16 million people living with Type 1 Diabetes.
0 investors